This site is intended for Healthcare professionals only.
×

Natco Pharma launches Hepatitis C drug in Nepal

Natco Pharma launches Hepatitis C drug in Nepal

New Delhi: Natco Pharma today said it has launched generic Hepcinat LP, which is in the treatment of chronic hepatitis C infection in adults, in Nepal.

NATCO priced its generic medicine, Hepcinat LP, at Rs 25,000 for a bottle of 28 tablets in Nepal, the company said in a filing to the BSE.

Hepcinat LP is generic version of Ledipasvir and Sofosbuvir combination and is used in the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.

Natco had signed a non-exclusive licensing agreement with Gilead Sciences earlier in 2015, to manufacture and sell generic versions of its chronic hepatitis C medicines, including generic version of HARVONI, in India and other 100 developing countries.

0 comment(s) on Natco Pharma launches Hepatitis C drug in Nepal

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
    Source: PTI

    Opinion Polls

    Should Government Doctors be allowed to do Private Practice?